Arbutus Biopharma
Kevin Gray's work experience includes various roles in the pharmaceutical and biopharmaceutical industry. Kevin began their career in 1995 as a Research Assistant at Deborah Research Institute, where they worked in Morphology/Biochemical Pharmacology. In 1996, they moved to the University of Pennsylvania as a Research Specialist in the Institute for Human Gene Therapy's Cellular Morphology Unit. From 1997 to 2003, Kevin worked at BMS, initially as a Molecular Pathology Supervisor and later as an Associate Director in various medical and clinical operations roles, including Virology Medical/Clinical Operations and Global Medical Operations Lead for Hepatitis C. In 2014, they became an Associate Director of Medical Publication Operations Lead - Immuno-Oncology. From 2015 to 2017, Kevin served as the Category Lead Global Procurement RD Discovery at BMS. In 2018, they joined Vertex Pharmaceuticals/PRA Health Sciences as a Clinical Operations Project Management Lead. Most recently, starting from 2019, Kevin has been with Arbutus Biopharma Corporation, initially as a Director of Clinical Operations and now as a Senior Director of Clinical Operations.
Kevin Gray holds a Bachelor of Science degree in Biology from The College of New Jersey. No other education history is provided.
This person is not in any offices
Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).